Sa abiso ng dalawang kumpanya, lumabas sa final efficacy analysis sa phase 3 study na 95 porsyentong epektibo ang kanilang bakuna.…
Subscribe to our newsletter!
By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.
